Cargando…
Epstein‐Barr Virus‐encoded Latent Membrane Protein 1 Co‐expresses with Epidermal Growth Factor Receptor in Nasopharyngeal Carcinoma
Latent membrane protein 1 (LMP‐1) is the only Epstein‐Barr virus (EBV)‐encoded oncogenic protein that has been detected in nasopharyngeal carcinoma (NPC), a cancer that is closely associated with EBV. Previous in‐vitro studies have demonstrated that LMP‐1 can upregulate epidermal growth factor recep...
Autores principales: | Sheen, Tzung‐Shiahn, Huang, Yu‐Tzu, Chang, Yih‐Leong, Ko, Jenq‐Yuh, Wu, Chung‐Shun, Yu, Yu‐Chen, Tsai, Ching‐Hwa, Hsu, Mow‐Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926033/ https://www.ncbi.nlm.nih.gov/pubmed/10665644 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00710.x |
Ejemplares similares
-
The role of Epstein–Barr virus in nasopharyngeal carcinoma
por: Su, Zhi Yi, et al.
Publicado: (2023) -
Therapeutic Evaluation of Epstein-Barr Virus-encoded Latent Membrane Protein-1 Targeted DNAzyme for Treating of Nasopharyngeal Carcinomas
por: Cao, Ya, et al.
Publicado: (2014) -
Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma
por: Salano, Valerie E., et al.
Publicado: (2021) -
The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma
por: Fan, Chunmei, et al.
Publicado: (2018) -
DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas
por: Liao, Wei-Hua, et al.
Publicado: (2014)